According to GuruFocus Insider Data, these are the largest CEO sales during the past week: OCZ Technology Group Inc, Workday Inc, Gilead Sciences Inc, Natus Medical Inc.
OCZ Technology Group Inc. (OCZ, Financial): President and CEO Ralph H Schmitt sold 372,340 Shares
President and CEO of OCZ Technology Group Inc. (OCZ) Ralph H Schmitt sold 372,340 shares on 12/03/2013 at an average price of $0.2. OCZ Technology Group, Inc., a Delaware corporation was formed in 2002. Ocz Technology Group Inc. has a market cap of $7.441 million; its shares were traded at around $0.11 with and P/S ratio of 0.05. Ocz Technology Group Inc. had an annual average earnings growth of 51.10% over the past 5 years.
OCZ Technology Group Inc announced their 2014 fiscal second quarter results. The Company reported revenues of $33.5 million and net loss of $26.1 million.
President and CEO Ralph H Schmitt sold 372,340 shares of OCZ stock on 12/03/2013 at the average price of 0.2.
Workday Inc (WDAY, Financial): Co-CEO, 10% Owner David A Duffield sold 348,126 Shares
Co-CEO, 10% Owner of Workday Inc (WDAY) David A Duffield sold 348,126 shares on 12/03/2013 at an average price of $79.97. Workday, Inc. was incorporated in March 2005 as North Tahoe Power Tools, Inc. Workday Inc has a market cap of $14.25 billion; its shares were traded at around $81.44 with and P/S ratio of 34.08.
Workday Inc reported their 2014 fiscal third quarter results with revenues of $127.9 million and net loss per basic and diluted share of $0.27.
Co-CEO, 10% Owner David A Duffield sold 523,504 shares of WDAY stock in September and August. CFO Mark S Peek sold 40,000 shares of WDAY stock on 09/17/2013 at the average price of 76.44. President and COO Michael A. Stankey and VP, General Counsel & Secty James P Shaughnessy sold 56,032 shares of WDAY stock in October and December.
Gilead Sciences Inc (GILD, Financial): Chairman and CEO John C Martin sold 282,242 Shares
Chairman and CEO of Gilead Sciences Inc (GILD) John C Martin sold 282,242 shares on 12/02/2013 at an average price of $74.26. Gilead Sciences, Inc. was incorporated in Delaware on June 22, 1987. Gilead Sciences Inc has a market cap of $113.45 billion; its shares were traded at around $73.99 with a P/E ratio of 40.50 and P/S ratio of 11.60. Gilead Sciences Inc had an annual average earnings growth of 14.80% over the past 5 years.
With revenues of $2.8 billion and net income of $788.6 million, Gilead Sciences Inc reported their 2013 third quarter financial results.
Chairman and CEO John C Martin sold 1,411,210 shares of GILD stock from August to December. SVP, CFO Robin L Washington sold 84,069 shares of GILD stock in July, September, and November. EVP, Corp & Med Affairs Gregg H Alton, EVP, Commercial Operations Kevin Young¸ Director Etienne Davignon, and President and COO John F Milligan sold 906,047 shares of GILD stock in November and December.
Natus Medical, Inc. (BABY, Financial): President & CEO James B Hawkins sold 206,878 Shares
President & CEO of Natus Medical, Inc. (BABY) James B Hawkins sold 206,878 shares on 12/04/2013 at an average price of $22.58. Natus Medical Incorporated, a Delaware corporation was incorporated in May 1987. Natus Medical, Inc. has a market cap of $688.944 million; its shares were traded at around $22.28 with a P/E ratio of 37.40 and P/S ratio of 2.01.
Nauts Medical Inc announced their 2013 third quarter results. The Company reported net income of $6.3 million and revenues of $85.4 million.
President & CEO James B Hawkins sold 229,068 shares of BABY stock in August and December. Director William M Moore, VP Medical Affairs, QA/RA Dong Chune Christopher Chung¸ VP Marketing and Sales Kenneth M Traverso, and Director Doris Engibous sold 95,816 shares of BABY stock from September to November.
For the complete list of stocks that bought by their CEOs, go to: Insider Buys.
OCZ Technology Group Inc. (OCZ, Financial): President and CEO Ralph H Schmitt sold 372,340 Shares
President and CEO of OCZ Technology Group Inc. (OCZ) Ralph H Schmitt sold 372,340 shares on 12/03/2013 at an average price of $0.2. OCZ Technology Group, Inc., a Delaware corporation was formed in 2002. Ocz Technology Group Inc. has a market cap of $7.441 million; its shares were traded at around $0.11 with and P/S ratio of 0.05. Ocz Technology Group Inc. had an annual average earnings growth of 51.10% over the past 5 years.
OCZ Technology Group Inc announced their 2014 fiscal second quarter results. The Company reported revenues of $33.5 million and net loss of $26.1 million.
President and CEO Ralph H Schmitt sold 372,340 shares of OCZ stock on 12/03/2013 at the average price of 0.2.
Workday Inc (WDAY, Financial): Co-CEO, 10% Owner David A Duffield sold 348,126 Shares
Co-CEO, 10% Owner of Workday Inc (WDAY) David A Duffield sold 348,126 shares on 12/03/2013 at an average price of $79.97. Workday, Inc. was incorporated in March 2005 as North Tahoe Power Tools, Inc. Workday Inc has a market cap of $14.25 billion; its shares were traded at around $81.44 with and P/S ratio of 34.08.
Workday Inc reported their 2014 fiscal third quarter results with revenues of $127.9 million and net loss per basic and diluted share of $0.27.
Co-CEO, 10% Owner David A Duffield sold 523,504 shares of WDAY stock in September and August. CFO Mark S Peek sold 40,000 shares of WDAY stock on 09/17/2013 at the average price of 76.44. President and COO Michael A. Stankey and VP, General Counsel & Secty James P Shaughnessy sold 56,032 shares of WDAY stock in October and December.
Gilead Sciences Inc (GILD, Financial): Chairman and CEO John C Martin sold 282,242 Shares
Chairman and CEO of Gilead Sciences Inc (GILD) John C Martin sold 282,242 shares on 12/02/2013 at an average price of $74.26. Gilead Sciences, Inc. was incorporated in Delaware on June 22, 1987. Gilead Sciences Inc has a market cap of $113.45 billion; its shares were traded at around $73.99 with a P/E ratio of 40.50 and P/S ratio of 11.60. Gilead Sciences Inc had an annual average earnings growth of 14.80% over the past 5 years.
With revenues of $2.8 billion and net income of $788.6 million, Gilead Sciences Inc reported their 2013 third quarter financial results.
Chairman and CEO John C Martin sold 1,411,210 shares of GILD stock from August to December. SVP, CFO Robin L Washington sold 84,069 shares of GILD stock in July, September, and November. EVP, Corp & Med Affairs Gregg H Alton, EVP, Commercial Operations Kevin Young¸ Director Etienne Davignon, and President and COO John F Milligan sold 906,047 shares of GILD stock in November and December.
Natus Medical, Inc. (BABY, Financial): President & CEO James B Hawkins sold 206,878 Shares
President & CEO of Natus Medical, Inc. (BABY) James B Hawkins sold 206,878 shares on 12/04/2013 at an average price of $22.58. Natus Medical Incorporated, a Delaware corporation was incorporated in May 1987. Natus Medical, Inc. has a market cap of $688.944 million; its shares were traded at around $22.28 with a P/E ratio of 37.40 and P/S ratio of 2.01.
Nauts Medical Inc announced their 2013 third quarter results. The Company reported net income of $6.3 million and revenues of $85.4 million.
President & CEO James B Hawkins sold 229,068 shares of BABY stock in August and December. Director William M Moore, VP Medical Affairs, QA/RA Dong Chune Christopher Chung¸ VP Marketing and Sales Kenneth M Traverso, and Director Doris Engibous sold 95,816 shares of BABY stock from September to November.
For the complete list of stocks that bought by their CEOs, go to: Insider Buys.
